Revolutionizing the traditional
fertility process
through
innovative therapeutics

Cell engineering is curing diseases from cancer to heart disease. We believe novel advances in the field can improve and modernize the entire female reproductive journey.

We are here to make a change.

Ovarian decline affects women throughout their lifetime, causing disease of the female reproductive system, infertility, and menopause. Most of these conditions have few treatment options, and those that do exist cause complications and don’t cure the underlying disease.

At the core of our work is cell engineering. We are using it to modernize and destigmatize the traditional fertility process.

US Headquarters:
New York, NY
European Headquarters:
Madrid, Spain

We bring together scientists, innovators, and experts passionate about modernizing and improving women's health

Dina Radenkovic
Co-founder & Chief Executive Officer
Teri Loxam
Chief Financial Officer
Christian Kramme
Vice President of Cellular Engineering
Agustina Imfeld
Counsel
Milos Fulton
Vice President of Business Operations
Sabrina Piechota
Embryology Department Manager
Emily Bosworth
Business Development Manager
Bruna Paulsen
Manufacturing Manager
Dina Radenkovic
Dina Radenkovic
CEO and Director
Martin Varsavsky
Martin Varsavsky
Chairman
Maryanna Saenko
Maryanna Saenko
Director
Dylan Morris
Dylan Morris
Director

Scientific Advisory Board

Professor George Church
Professor George Church
Professor Kristin Baldwin
Professor Kristin Baldwin
Professor Philip Jordan
Professor Philip Jordan
Dr Sara Vaughn
Dr Sara Vaughn
Professor Mary Herbert
Professor Mary Herbert
Professor Pranam Chatterjee
Professor Pranam Chatterjee

Bioethics Committee

Alta Charo
Alta Charo
Leslie Schrock
Leslie Schrock
Andrew Mclaughlin
Andrew Mclaughlin

Join us

If you’re interested in joining our mission-driven team and would like to contribute to our work, please take a look at our open positions or get in touch.

Careers

Our investors help us modernize and improve women's health

Future
Insight Partners
Bold
Arcadia
Plumalley
Lux
TAV
Salt
FJ Labs
Overwater Ventures
Anne Wojcicki
Anne Wojcicki
23 and Me
Robert Nelsen
Robert Nelsen
Arch Ventures
Jack Abraham
Jack Abraham
Atomic
Dan Rose
Dan Rose
Coatue Ventures